Literature DB >> 12478770

Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2.

John H Thurston1, Elodie M Marlier, Kenton H Whitmire.   

Abstract

The synthesis and characterization of the first bismuth salicylate complexes, stabilized by chelating amine ligands, offers the possibility for detailed investigation of molecular precursors of the biologically significant compound bismuth subsalicylate (BSS).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478770     DOI: 10.1039/b209188g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

1.  Structure of the active pharmaceutical ingredient bismuth subsalicylate.

Authors:  Erik Svensson Grape; Victoria Rooth; Mathias Nero; Tom Willhammar; A Ken Inge
Journal:  Nat Commun       Date:  2022-04-13       Impact factor: 14.919

2.  Crystal structure, antibacterial and cytotoxic activities of a new complex of bismuth(III) with sulfapyridine.

Authors:  Ivana M Marzano; Marina S Franco; Priscila P Silva; Rodinei Augusti; Geandson C Santos; Nelson G Fernandes; Mônica Bucciarelli-Rodriguez; Edmar Chartone-Souza; Elene C Pereira-Maia
Journal:  Molecules       Date:  2013-01-24       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.